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Summary 
The aim of this study was to develop an immunization procedure avoiding external adjuvant. 
Data are presented showing that syngeneic dendritic cells (DC), which have been pulsed in vitro 
with antigen, induce a strong antibody response in mice. By contrast, antigen (Ag)-pulsed low- 
density B cells, although equally able to induce interleukin 2 secretion by an Ag-specific T cell 
hybridoma in vitro, only weakly prime the mice in vivo. Moreover, we show that the injection 
of Ag-pulsed DC induces the synthesis of isotypes similar to the immunoglobulin classes detected 
after immunization with the same Ag in complete Freund's adjuvant. Importantly, high amounts 
of IgG2a antibodies are produced, suggesting that T helper type I cells are activated. Collectively, 
these data indicate that DC can initiate a primary humoral response and that they may be used 
as physiological adjuvant  in vivo. 
T 
he induction of immune responses in vivo is typically 
performed with antigens administered in artificial adju- 
vants, like alum and CFA (1). However, the discovery of den- 
dritic cells (DC) 1 (2), which most efficiently activate a pri- 
mary T  cell response in vitro (3), suggests that these cells 
could be used to induce antibody responses in situ, avoiding 
the use of toxic adjuvants. These cells have some unique prop- 
erties in vivo, as compared with the other APC: they are 
widely distributed in lymphoid as well as in nonlymphoid 
tissues (reviewed in reference 4); they seem to be the major 
source of processed antigen in vivo (5); and they home to 
the T-dependent  region of lymph nodes and spleen (6, 7). 
DC appear to play a major role in initiating various T cell 
immune responses in vivo, such as contact sensitivity (8-10), 
allograft rejection (11-14), and activation of MHC-restricted 
T  cell responses (15). Taken together, these results suggest 
that injection of in vitro pulsed DC may provide an efficient 
way for inducing T-dependent immunity without the use of 
external  adjuvant. 
Little is known, however, about the induction by DC of 
specific B cell responses in vivo. Indeed, although it has been 
shown in our laboratory that mouse dendritic cells, pulsed 
in vitro with tobacco mosaic virus, could strongly enhance 
the primary and the secondary responses to the virus (16), 
1  Abbreviations used in this paper: Ag, antigen; DC, dendritic cell; HGG, 
human gamma globulin. 
similar data could not be obtained with other antigens like 
soluble proteins. 
Recent studies (15, 17) clearly showed that the capacity 
of the DC population to process and present  proteins was 
downregulated when the dendritic cells matured in culture. 
In this report, we show that injection of DC appropriately 
pulsed in vitro with soluble protein antigens induces strong 
specific humoral responses in vivo. 
Materials and Methods 
Mice.  Female  DBA/2 mice (H-2d), 6-8  wk old, were pur- 
chased from Charles Kiver Wiga (Sulzfeld, Germany). 
Antigens.  The antigens used  in this study were Myoglobin  from 
sperm whale skeletal muscle and gamma-globulin from human 
blood, fraction II (both from Fluka Chemie AG, Buchs, Swit- 
zerland). 
Culture Medium.  The complete culture medium used in all ex- 
periments was RPMI 1640 (Seromed; Biochem KG, Berlin Ger- 
many) supplemented  with 10%  FCS (Byosis S.A.,  Compi~gne, 
France),  penicillin,  streptomycin, nonessential  amino acids,  so- 
dium pyruvate,  2-ME  and L-glutamine  (Flow ICN Biomedicals 
Bucks, UK). 
T Cell Hybridoma.  The I-Ed-restricted, myoglobin-specific hy- 
bridoma 13-26-8-HG.1 was derived by Dr. A. Livingstone (Basel 
Institute of Immunology, Basel, Switzerland). 
Antigen-presenting Cells.  Spleens  were digested with collagenase 
(CLS III; Worthington Biochemical  Corp., Freehold,  NJ) and sepa- 
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minar Cohn fraction V powder; Armour Pharmaceutical Co., Tar- 
rytown, NY). The spleen DC were purified according to a procedure 
described by Crowley et al.  (18). Briefly, low-density cells were 
cultured during 2 h in 10% FCS-containing medium and the nonad- 
herent cells were removed by vigorous pipetting. The same proce- 
dure was repeated with a shorter (1 h) incubation  without FCS. 
After overnight culture,  nonadherent  cells contain at least 90% 
of dendritic cells (as assessed  by morphology and specific staining). 
To obtain low-density B cells, the nonadherent cells obtained after 
the 2-h incubation  (before vigorous pipetting)  were depleted of 
T cells. For convenience, these low density, nonadherent, T-depleted 
spleen cells will be called low-density B cells. 
Antigen Pulsing of  APC.  For dendritic cell pulsing, the adherent 
cells of the low-density fraction of spleen were cultured overnight 
in complete medium containing 100 #g/ml of antigen. The nonad- 
herent cells were then collected and were mainly DC (referred to 
as antigen [Ag]-pulsed DC). The low-density B cells were cultured 
in the same conditions and all cells were collected after overnight 
culture. 
11.,2 Production by T Cell Hybridoma.  The T cell hybridoma was 
cuhured with varying numbers of APC in the presence of intact 
protein in complete culture medium in 96-well fiat-bottomed mi- 
crotiter plates. After a 24-h culture period, the supernatants were 
assayed for Ib2 using an II.,2-sensitive subline of the CTLL call 
line (19). A total of l& cells were incubated with the supematants 
and 0.5 #Ci [3H]TdR.  was added per well during the final 6-16 h 
of culture. Cells were harvested, and incorporation of radioactivity 
was assessed as described above. 
Determination of Antigen-specific Antibody Levels.  Serum levels 
of antigen-specific antibodies were determined by ELISA according 
to standard procedures using polyclonal goat anti-mouse IgG re- 
agent (Boehringer Mannheim Biochemicals, Mannheim, Germany) 
or isotype-specific rat mAbs (20). Antibody titers were calculated 
based on linear regression analysis of the optical densities. Results 
are expressed as titers determined using the midpoint of the titra- 
tion curves relative to an internal  standard run in each assay. 
Immunization Protocols.  For primary response, mice received an 
intravenous injection of 3  x  105 Ag-pulsed syngeneic DC. Con- 
trol mice were injected with unpulsed DC, Ag-pulsed low-density 
B cells, or were left untreated.  5 d later, all mice received a boost 
of 100 #g of soluble antigen  intravenously, except one group of 
untreated mice which was injected intraperitoneally with 100 #g 
of antigen emulsified in CFA. All mice were bled 7 or 8 d after 
the antigen boost. For secondary response, all groups of mice re- 
ceived an injection of 100 #g of soluble antigen intravenously 1 
mo after the initial  treatment  and were bled 7 d later. 
Results 
Fresh Splenic Dendritic Cells Present Native Proteins In Vitro. 
The initiation  of any T cell response requires two indepen- 
dent steps: Ag presentation and T cell sensitization. Ag pre- 
sentation generates the ligand that is recognized by the or//3 
heterodimer of the clonally specific portion of the TCK for 
Ag,  and usually requires the generation  of small peptides. 
Although it is clear that  purified splenic DC have a poor, 
if any, capacity for processing, data from Romani et al. (17) 
clearly showed that handling  of intact proteins was down- 
regulated in cultured as compared with fresh epidermal Lange- 
rhans cells. More recently, Inaba et al. (15) showed that fresh 
splenic DC were able to process native proteins early,  i.e., 
during the purification procedure of the DC.  In a prelimi- 
nary experiment, we compared the ability of dendritic ceils 
and control cells to process and present myoglobin in vitro. 
We used a T cell hybridoma, since its activation only requires 
TCK occupancy, i.e., the presence of the appropriate antigen 
in the context of self MHC,  and does not depend on any 
costimulatory signal (21).  As control APC, we chose cells 
that were isolated from the same low-density fraction as the 
dendritic cells, but were nonadherent during the 2-h culture 
and were depleted of T cells (see Material and Methods). Fig. 
1 shows that both APC populations (DC or low-density B 
cells), pulsed during overnight culture, strongly induce Ib2 
secretion by a myoglobin-specific T cell hybridoma. The two 
types of APC, however, have distinct properties. Indeed, 24- 
h-old,  purified DC cultured with antigen only slightly in- 
duce the activation of the T  cell hybridoma, whereas 24-h- 
old low-density B cells very efficiendy present  the antigen 
in  the same conditions. 
Dendritic Cells Pulsed In Vitro with Antigen Induce a Specific 
Humoral Response In Viva  To evaluate the ability of DC to 
induce an in vivo humoral response, syngeneic DC were pulsed 
with myoglobin during overnight culture and 3  x  105 cells 
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Figure 1.  Fresh DC process native antigen in culture.  Fresh DC and 
low-density B cells were cultured overnight in complete medium containing 
myoglobin (DC"omyo  and LoB~myo). Cells were washed, counted,  and 
cultured with 3  x  104 "I:r hybridoma  cells (13-26-8). 24-h culture su- 
pernatants were assayed for IL-2 production in response to antigen-specific 
stimulation. Control APC (/~ and LoB) were cultured without Ag during 
the  purification  steps  and  were  cultured  with  hybridoma  cells  with 
( + Myo) or without ( +  medium)  addition of antigen.  Three e~periments 
were performed  with similar results. 
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later, animals were injected with 100/zg of antigen in saline. 
Control groups included mice injected with soluble antigen 
only, and mice that received unpulsed DC and the antigen 
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boost. The data in Fig. 2 a show that in vivo administration 
of Ag-pulsed DC induced a strong humoral response upon 
challenge with soluble antigen, whereas control mice pro- 
duced little specific antibodies.  Similar data were obtained 
with human gamma globulin (HGG): DBA/2 mice injected 
with HGG-pulsed DC and boosted with the same antigen 
in saline synthesized high amounts of antibodies specific for 
HGG (Fig.  2 b). 
The Isotype Pattern Reflects the Activation of ThI  Cells In 
Viva  Recent studies indicate that unique cofactors are neces- 
sary for the selective activation of cloned routine CD4 + cells 
representing Thl and Th2 cells and that these factors are pro- 
duced by specialized APC populations (22). Since the regu- 
lation of isotype switching in vivo is dependent upon the 
activation of different types of T helper cells (23), we inves- 
tigated the class distribution of the specific antibodies.  Fig. 
3 summarizes the isotypes of the myoglobin-specific antibodies 
from mice tested individually in two independent experiments. 
The data show that high concentrations of IgG1 and variable 
but elevated amounts of IgG2a are secreted in the primary 
and secondary responses of DBA/2 mice primed with antigen- 
pulsed syngeneic DC. The injection of Ag-pulsed low-density 
B cells induces a low primary response, but the level of specific 
antibodies is increased after the antigen boost. Similar data 
were obtained in three independent experiments for the pri- 
mary and secondary responses specific for HGG: Fig. 4 shows 
that HGG-pulsed DC are as potent as CFA in inducing specific 
antibody responses  of IgG1 and IgG2a isotypes. 
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Figure 2.  Antigen-pulsed DC induce a primary humoral response in 
vivo. DBA/2 mice (at least five per group) were injected with 3  x  10  s 
myoglobin-pnlsed  (a) or HGG-pulsed  (b) DC and boosted  with 100/zg 
of the same  antigen  in saline (closed  squares). Control  groups  included  un- 
treated mice (diamonds), mice  injected  with unpulsed  DC (open  squares), 
and mice  that only received  soluble  Ag (circles). All mice  were bled 8 d 
after antigen  boost, and antigen-specific  antibodies  were measured  in in- 
dividual sera using a goat anti-mouse Ig reagent. 
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Discussion 
The major observation from this study is that syngeneic 
DC that have been pulsed in vitro with native proteins in- 
duce a strong specific B cell response in vivo in unprimed 
animals that are boosted with soluble antigen. Thus, extracor- 
poreal pulsing of DC may provide a physiological pathway 
for inducing T-dependent humoral responses  in vivo. 
The priming of naive animals by using elements of the 
immune system itself offers several advantages. It avoids the 
toxicity and the nonspecific immune activation often associated 
with the use of artificial adjuvants. Moreover, DC appear to 
very efficiently generate the antigenic epitopes (24, 25) that 
can be presented by self-MHC, and finally, the injection of 
DC promotes a specific memory B cell response. 
The potent "adjuvant" capacity of DC, as compared with 
low-density B cells, correlates with their unique properties 
in vivo (for review, see reference 4). In particular,  by down- 
regulating antigen processing (15, 17; Fig. 1), DC may not 
displace the acquired antigen with other antigens or with 
self proteins. This property appears to confer on the DC some 
"fidelity" to the Ag (15; and T. Sornasse, data not shown). 
Our results are in accordance with previous in vitro data 
showing  that  DC  are  required  for  the  development of 
T-dependent antibody response by mouse and human lym- 
phocytes in vitro (26, 27). In vivo, a number of experiments 
have shown that the B cell is the initiating APC in periph- 
eral lymph nodes (28-30), whereas other data suggest that 
non-B cells, "professional" APC, are required to initiate an ￿9 
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Figure  3.  Isotype  analysis  of 
myoglobin-specific primary and sec- 
ondary  responses.  Mice  were  in- 
jected on day 0 with either antigen- 
pulsed DC (DCr~Myo), unpulsed 
DC (DC), or antigen-pulsed low- 
density  B  cells  (LoBmMyo).  All 
groups of mice received 100/zg of 
soluble antigen on day 5. Control 
mice include one group that was in- 
jected with 100/~g of myoglobin 
emulsified in CFA and one group 
that only received 100 #g of soluble 
Ag on day 5. Total spedfic response 
(Total/2),  as well as specific anti- 
bodies of IgG1 or IGg2a isotypes, 
were measured as described in Ma- 
terials and Methods. 
anti-SRBC primary immune response (31). Our data empha- 
size the main role of DC in initiating primary responses in vivo. 
Low-density B cells,  purified from the same low-density 
floating fraction as DC, very efficiently present  myoglobin 
to T cell hybridoma in vitro. Nevertheless, they only induce 
a weak primary B cell response in vivo as compared with 
DC.  However, the antibody response induced by the injec- 
tion of low-density B cells is  significantly higher than the 
response observed after injection of soluble antigen.  Thus, 
low-density B  cells may contain a population  of cells  able 
to stimulate resting T cells and initiate a humoral response. 
These cells could be activated  B cells,  or alternatively  could 
be contaminating DC, since we detect ,ol-2% of DC in the 
preparation  (data not shown). 
When primed mice were boosted with soluble Ag, a sec- 
ondary response of greater amplitude is observed (Figs. 3 and 
4). These results demonstrate that priming with Ag-pulsed 
DC  elicits  a memory response. 
The effect of DC on antigen-specific responses most likely 
involves  helper  T  lymphocytes  which,  in  turn,  recognize 
MHC-compatible, antigen-stimulated B cells recirculating in 
the vicinity.  Optimal  sensitization  of T  cells  requires  two 
steps: an antigen-specific step, the occupancy of the TCR by 
Ag  +  MHC, and an Ag nonspecific step, the costimulatory 
signal delivered by the APC (32, 33). I1,1 seems to be a req- 
uisite costimulator for the growth of selected CD4 + Th2 
clones, whereas optimal Thl responses require a costimula- 
tory signal that could be the murine B7 (34). Since splenic 
DC do not appear to secrete or express  IL-1 (35), and since 
low-density splenic APC can replace the costimulator for Thl 
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Figure  4.  Isotype  analysis  of 
HGG-specific  primary  and  sec- 
ondary responses. Mice were either 
untreated  (Sol),  injected  with 
antigen-pulsed  DC  (D&vHGG), 
or  with unpulsed DC  (DC).  All 
groups were boosted with 100 #g 
of soluble antigen 5 d later. A group 
of mice received  100 #g of HGG 
emulsified in  CFA  (CFA). Total 
specific response (Total Ig), as well 
as specific antibodies  of IgG1  and 
IgG2a  isotypes,  were tested as de- 
scribed in Materials and Methods. 
cells (for review, see reference 36), it is tempting to speculate 
that injection of Ag-pulsed DC mainly activates Thl cells 
in vivo. 
The presence of IgG2a in most sera tested from mice primed 
with Ag-pulsed DC strongly supports this hypothesis.  It has 
indeed been shown that clones of Thl type specifically in- 
duced Ag-specific B cells to secrete IgG2a (37). Work is in 
progress to characterize the lymphokine pattern produced by 
Ag-specific,  CD4 + T  cells  isolated  from the mice primed 
with Ag-pulsed DC. 
It is of note that the synthesis of specific antibodies of IgG2a 
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isotype is of physiological importance since this isotype has 
been shown to play a central role in the elimination of an- 
tigen in vivo (38, 39). 
We think that Ag-pulsed DC could instruct a T  helper 
lymphocyte,  uncommitted  in  its  lymphokine pattern,  to 
differentiate into a Thl type lymphocyte.  The choice between 
Thl and Th2 could therefore be due to the nature of the 
cell that  presents  antigen. 
In conclusion, DC may be used as a physiological adju- 
vant to induce cellular (15) and T  ceU-dependent  humoral 
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